Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts
about
Occlusion regulates epidermal cytokine production and inhibits scar formationGrowth factors in idiopathic pulmonary fibrosis: relative rolesCytokine and anti-cytokine therapies in prevention or treatment of fibrosis in IBDRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesReactive oxygen species and fibrosis: further evidence of a significant liaisonIloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patientsImmunohistochemical localization of connective tissue growth factor, transforming growth factor-beta1 and phosphorylated-smad2/3 in the developing periodontium of ratsContext-dependent switch in chemo/mechanotransduction via multilevel crosstalk among cytoskeleton-regulated MRTF and TAZ and TGFβ-regulated Smad3Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis.New molecular medicine-based scar management strategiesStructural remodelling of the sinoatrial node in obese old rats.Early effects of Staphylococcus aureus biofilm secreted products on inflammatory responses of human epithelial keratinocytesRecombinant expression, purification, and functional characterisation of connective tissue growth factor and nephroblastoma-overexpressed proteinMolecular changes during skin aging and wound healing after fractional ablative photothermolysis.The effect of the pro-inflammatory cytokine tumor necrosis factor-alpha on human joint capsule myofibroblasts.Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton.Emerging targets for the treatment of scleroderma.Development of agents for the treatment of systemic sclerosis.Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism.The Notch ligand Delta-like 1 integrates inputs from TGFbeta/Activin and Wnt pathways.Preventative effect of Astragalus flavescens on hepatic fibrosis in rats and its mechanism of action.Connective tissue growth factor: an attractive therapeutic target in fibrotic renal disease.Constitutive ALK5-independent c-Jun N-terminal kinase activation contributes to endothelin-1 overexpression in pulmonary fibrosis: evidence of an autocrine endothelin loop operating through the endothelin A and B receptors.Loss of tumor necrosis factor alpha potentiates transforming growth factor beta-mediated pathogenic tissue response during wound healing.Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease.Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosisA Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related FibrosisInhibition of Rho kinase modulates radiation induced fibrogenic phenotype in intestinal smooth muscle cells through alteration of the cytoskeleton and connective tissue growth factor expressionAngiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways.Idiopathic pulmonary fibrosis: emerging concepts on pharmacotherapy.Angiotensin II increases connective tissue growth factor in the kidney.The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis.mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis.Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts.Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase.Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells.TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease.Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?CCN2 suppresses catabolic effects of interleukin-1β through α5β1 and αVβ3 integrins in nucleus pulposus cells: implications in intervertebral disc degeneration.
P2860
Q24631725-A742D2D7-8C33-4262-B97A-8F3E20A43844Q24798972-FD6C380D-E7D1-4DD7-AC5F-232CBB914F7FQ26740540-02653ECE-84F4-4C44-8ADA-32D1A71B3611Q26786129-88A5533B-C755-4B66-8D45-358BF6F54CE7Q28077930-DA114BE8-574A-4FD1-9000-67E229B35183Q28344134-5E4D0536-D144-4675-A337-35E6AA961CDBQ28580521-0F9C116E-2C20-4D94-8B33-1ED539C79351Q28833739-B3222478-352A-44AF-B7DA-6C2869E59AD8Q30443462-8AC04586-3189-49F2-B157-0B06EFAAE5E6Q33560989-2ED7D171-3B29-46B9-AD5A-A8196A0F8F0BQ33754290-1AD60057-A1F5-4E92-810F-24F7BB54E90EQ33761051-EE3CE42E-17F4-44D4-83D5-85BDDA902F54Q33786810-B4CF90CD-8C42-4898-AA82-B3095FB570D2Q33791170-057E88C8-9AC6-459A-93BA-CBD1427FFA72Q33873615-6E5675A2-593C-4150-9BDA-E6F105A92866Q34227149-F08262EF-5170-4BB1-8128-BDBBB579DE59Q34270856-699D1B1D-0C4A-44B0-ACAC-CCE60A7A16F3Q34481552-B9FB5C99-417E-4BB1-BD54-3C450FB71835Q34797834-CCB3EE77-6BC4-4958-8C14-24D97E572798Q34989697-4F155C3D-A30A-4BDC-82E2-3802C2C3D391Q35020230-322EE23B-35CF-4AF6-9E22-342F58546533Q35050392-A11DDC34-61E7-4DFF-BAB6-4E1959C703D9Q35070899-C6AEFB6E-5AAE-48CB-A387-C3CD8E8D63FFQ35088370-FD609C1A-E4DF-47DA-A232-D08104F1C269Q35094477-E0CCFBC5-DA99-44A7-B75D-6AA44757E908Q35555901-9F3F1B46-5E20-43C3-8FBE-74D2C7F7E682Q35587696-868C7FDA-C493-4CA0-ADBC-0DD439BB6FFFQ35597228-C2B0B423-B364-4E52-9F68-CEF11C617F82Q35791591-E175D584-EAC4-4FC7-AB89-672038E26328Q35841561-3F77820E-3B53-4AF0-8C23-23ABE53E4B6DQ35843514-A763FFA8-639B-4BB3-966B-58E29ACE4A58Q35976816-DEB78DEF-FECE-4433-A244-4A1FDC6D527AQ36537631-0227B8A5-4469-4F23-A5FD-9BDF409D3DCEQ36724904-E92FB3BE-D9F4-4C91-90E5-EB9658019FDFQ36744942-CBE104F9-2C0E-4EB1-8E9C-EA0E7835A4ABQ36942777-B2BDDE61-6EDD-417F-93F7-4F5E7219B4B0Q36943410-11659912-A905-4676-8971-7264B4EDB49BQ37112937-1A2A95C4-1333-4312-9C5F-F017D92F2690Q37373460-83784440-76BD-4E7E-A362-ECE7CE132D54Q37635765-B43C876D-72C1-431F-ABF1-CC037FED814C
P2860
Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@ast
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@en
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@nl
type
label
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@ast
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@en
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@nl
prefLabel
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@ast
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@en
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@nl
P2093
P921
P3181
P356
P1476
Tumor necrosis factor alpha su ...... al and scleroderma fibroblasts
@en
P2093
P304
P3181
P356
10.1074/JBC.275.20.15220
P407
P577
2000-05-19T00:00:00Z